Institutional Investors Bet Big on Rocket Lab as Retail Sellers Push Shares to Oversold Depths
Published on 07/29/2026 at 13:41 | Redaktion boerse-global.de
The gap between what Rocket Lab’s shares trade for and what analysts think they’re worth has rarely been wider. At €55.60, the stock sits 58.45% below its May peak of €133.80, yet the average analyst price target of €100.52 implies an 80% upside. That disconnect has drawn in some of the market’s biggest players even as the broader sell-off continues.
Bank of Nova Scotia disclosed on July 29 that it had boosted its Rocket Lab position by a staggering 149.8%. The timing is telling: the institution added shares during a period when the stock lost nearly 36% in just 30 days. Other large capital providers appear to be following suit, quietly building positions while retail sentiment sours.
The Iridium Financing Question
The primary catalyst for the recent slide isn’t operational — it’s financial. Rocket Lab’s announcement of its $8 billion acquisition of satellite operator Iridium Communications triggered a reassessment of the company’s risk profile. The $3.6 billion bridge loan secured to fund the cash portion of the deal has introduced significant leverage to a stock whose 30-day annualized volatility has already climbed to nearly 89%.
That debt load is what bears are pricing in, not a deterioration in the underlying business. The annualized volatility figure alone suggests the market is struggling to find equilibrium on a name that has become as much a sentiment barometer for the space sector as a reflection of its own execution.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A Record Government Win That Couldn’t Stop the Bleeding
On July 21, the U.S. Space Force awarded Rocket Lab a $266 million contract for 12 suborbital missions from the Kodiak launch facility in Alaska. It’s the largest government launch contract in the company’s history, representing roughly 39% of trailing twelve-month revenue. Options for additional missions through 2028 are attached.
The stock did tick up on the news, but the relief was short-lived. That’s because the sell-off isn’t about launch frequency or the order book. SpaceX, the industry bellwether, has roughly halved since its post-IPO high in June, dragging the entire space complex lower. Rocket Lab is being swept up in a sector-wide revaluation, not punished for missing its own marks.
Neutron: The Catalyst Clock Is Ticking
Behind the financing overhang lies a longer-term question: the Neutron rocket program. The medium-lift vehicle has already secured five firm commercial missions before its first flight, and the order book is filling rapidly. But public updates on hardware progress have been sparse since January, creating an uncomfortable contrast with the pace of commercial commitments.
Rocket Lab still targets the fourth quarter of 2026 for Neutron’s debut, a timeline that has already slipped twice in just over a year. A third delay would remove the single most important catalyst that analysts anchor their price targets to. The company’s balance sheet offers some cushion — $2.2 billion in backlog and over $2 billion in available liquidity at the end of the first quarter — but time is not an infinite resource.
Institutions See a Buying Opportunity
The divergence between price action and institutional behavior is striking. While the 14-day RSI hovers near 32, deep in oversold territory, and the stock trades 35% below its 50-day moving average, entities like Bank of Nova Scotia are adding aggressively. Citizens maintained its “Market Outperform” rating with a $130 price target following the Space Force win, citing progress on Neutron and the strategic logic of the Iridium acquisition.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Three factors are likely to shape the narrative going forward: the clean execution of the Iridium financing, continued Neutron development milestones, and the company’s fast-growing role in national security. The Victus Haze mission for the Space Force, completed on July 7 in record time, underscored Rocket Lab’s rapid-response capabilities in the defense arena.
What the August 10 Earnings Will Reveal
Rocket Lab has confirmed it will report second-quarter results after U.S. markets close on Monday, August 10. Investors will be looking for concrete details on Iridium integration plans, the capital expenditure roadmap for expanding the Alaska launch site, and any updates on Neutron’s hardware progress.
The stock’s year-to-date performance remains positive at 45%, a reminder that the long-term growth story — built on government contracts, a growing backlog, and the Iridium transformation — hasn’t been invalidated. But the short-term path depends on whether Rocket Lab can convince the market that its $3.6 billion debt question has a clean answer, and that Neutron’s countdown clock is still on schedule. Until then, the stock will remain what it has become: a high-volatility proxy for the entire space sector, rather than a clean read on its own operational momentum.
Ad
Rocket Lab Stock: New Analysis - 29 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
